Medpace Holdings, Inc. (MEDP)
Runs clinical trials that test new drugs and medical devices for pharmaceutical companies.
$589.51+0.00%Healthcare
StockGlow Score
Leaning Bullish
BearishBullish
1 year ago+41.2%
The outlook
MEDP is trading well above its long-term moving averages and sits near the upper end of its 52-week range. Analyst consensus leans toward Hold, with the average price target about 3% below current levels. The stock carries a relatively high trailing P/E of 35.3, reflecting investor expectations.
What’s behind the score
Analyst consensusHold — 2.9 avg of 12 analysts
Price trendAbove its 50- & 200-day averages
52-week range71% of the way from its 52-week low to high
Price targetAvg target -3% vs current price
Analyst price target
~12-month · 12 analysts$570.67average target-3.2% vs now
Now $589.51
Low $370.00High $692.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$16.45B
52-wk high
$677.90
52-wk low
$373.00
50-day avg
$491.58
200-day avg
$516.88
Trailing P/E
35.3